Cargando…
2423. Effectiveness and Safety of Ceftolozane/Tazobactam (TOL/TAZ) Use for Carbapenem-Resistant Pseudomonas Infections in Children
BACKGROUND: Evidence for ceftolozane/tazobactam use in children is limited. We describe herein the outcomes of children treated with TOL/TAZ for various types of infections caused by carbapenem-resistant Pseudomonas aeruginosa (CR-PA). METHODS: Retrospective analysis of children who received TOL/TAZ...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253856/ http://dx.doi.org/10.1093/ofid/ofy210.2076 |